Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organ Preservation in Advanced Laryngeal Cancer
NCT01073683Phase 2Unknown
- Sponsor
- Rabin Medical Center
- Start
- Apr 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in laryngeal cancer, sponsored by Rabin Medical Center. Status: unknown.
02
Drugs
docetaxel
03
Conditions
laryngeal cancer
Beyond the preview
Go deeper on NCT01073683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01073683.